Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet
- First Posted Date
- 2010-02-22
- Last Posted Date
- 2013-05-03
- Lead Sponsor
- Soumya Chatterjee
- Target Recruit Count
- 20
- Registration Number
- NCT01072669
- Locations
- 🇺🇸
Nilanjana Bose, Md, Cleveland, Ohio, United States
News
No news found